SHARE-BASED COMPENSATION - Additional Information (Details) (USD $)	12 Months Ended					12 Months Ended
	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2011	Dec. 31, 2013 Performance share units Minimum	Dec. 31, 2013 Performance share units Maximum	Dec. 31, 2013 Equity-classified share-based compensation arrangements	Dec. 31, 2013 Liability-classified stock appreciation rights	Apr. 11, 2013 2013 Plan	Dec. 31, 2013 2004 Plan and 1998 Plan	Dec. 31, 2013 2013 grants Performance share units	Dec. 31, 2013 2012 grants Performance share units	Dec. 31, 2013 2011 grants Performance share units
Deferred Compensation Arrangement with Individual, Share-based Payments [Line Items]
Share-based compensation expense	$ 42,000,000	$ 37,000,000	$ 25,000,000
Number of shares approved under the plan								10,000,000
Number of shares available for future grants under the Plan	19,902,470								9,000,000
Number of shares of stock options and stock appreciation rights an individual may receive in one year	2,000,000
Number of shares of restricted stock, restricted stock units, performance shares, performance share units or other equity grants an individual may receive in one year	1,000,000
Value of awards no participant may be granted in a 12 month period	10,000,000
Increase in common share if all share-based awards were exercised or vested	40,000,000
Total income tax benefit from share-based awards	10,000,000	9,000,000	6,000,000
Realized excess tax benefits	13,000,000	5,000,000	2,000,000
Final number of shares awarded of each grant's target				0.00%	150.00%					150.00%	122.00%	105.00%
Total shareholder return ranking in the S&P 500 during the first two years is used to adjust the initial number of units earned up or down					20.00%						17.00%	20.00%
Unrecognized share-based compensation cost						$ 43,000,000	$ 1,000,000
Unrecognized share-based compensation costs, weighted average period for recognition						2 years 110 days	1 year 180 days
Number of common shares issued for deferred compensation stock equivalent units	52,720	40,899
Number of common shares to be issued for directors who elected common share payments subsequent to year-end	557,519
Number of stock-equivalent units outstanding in deferred compensation accounts	915,160	971,650	1,021,977